Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vabysmo
Pharma
Regeneron touts Eylea HD launch, warns of potential approval delay
The strong launch of Regeneron's Eylea HD has helped the franchise to a rebound after U.S. sales had declined in each of the previous three quarters.
Kevin Dunleavy
Aug 1, 2024 11:15am
Sales for Roche's Vabysmo rise again, but momentum is stalled
Jul 25, 2024 11:45am
Roche's eye disease meds Vabysmo, Susvimo show extended efficacy
Jul 18, 2024 11:37am
FDA gives thumbs-up to Roche's Vabysmo in a prefilled syringe
Jul 8, 2024 10:35am
Bayer de-emphasizes the impact of Roche's Vabysmo on Eylea sales
May 14, 2024 11:46am
Genentech animated short spotlights docs' trust in Vabysmo
May 13, 2024 4:05pm
